FDA Issues Warning Letter to DeVere Manufacturing
December 10, 2025
December 10, 2025
WASHINGTON, Dec. 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to DeVere Manufacturing Inc. from the Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Randy D. Stevenson, President, DeVere Manufacturing Inc., 1923 Beloit Avenue, Janesville, WI 53546, United States, rstevenson@deverechemical.com
Issuing Office:, Center for Drug Evaluation and Research (CDER), United States . . .
* * *
Recipient: Mr. Randy D. Stevenson, President, DeVere Manufacturing Inc., 1923 Beloit Avenue, Janesville, WI 53546, United States, rstevenson@deverechemical.com
Issuing Office:, Center for Drug Evaluation and Research (CDER), United States . . .
